Evidence map›Paper›PMID 35577620›Full record

ReviewHealth policy (Amsterdam, Netherlands)2022

Follow-up regimes for sick-listed employees: A comparison of nine north-western European countries.

Solveig Osborg Ose, Silje Lill Kaspersen, Taina Leinonen, Suzanne Verstappen, Angelique de Rijk, Slavina Spasova, Sara Hultqvist, Iben Nørup, Jón R Pálsson, Andreas Blume and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Health policy (Amsterdam, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Uncovering the toll of the first three COVID-19 waves: excess mortality and social patterns in Belgium.Archives of public health = Archives belges de sante publique · 2024
    Article
  9. Article
  10. Clinical Work-Integrating Care in Current Practice: A Scoping Review.Journal of occupational rehabilitation · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 8 countries.

Solveig Osborg OseSINTEF Health Services Research, Klæbuveien 153, Trondheim 7037, Norway. Electronic address: solveig.ose@sintef.no.
Silje Lill KaspersenSINTEF Health Services Research, Klæbuveien 153, Trondheim 7037, Norway.
Taina LeinonenFinnish Institute of Occupational Health, Finland.
Suzanne VerstappenCentre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom.
Angelique de RijkDepartment of Social Medicine, Faculty of Health Medicine and Life Science, Care and Public Health Research Institute, Maastricht University, The Netherlands.
Slavina SpasovaEuropean Social Observatory, Belgium.
Sara HultqvistLund University, Sweden.
Iben NørupAalborg University, Denmark.
Jón R PálssonConfederation of Icelandic employers, Iceland.
Andreas BlumeRuhr Universität Bochum, Germany.
Mike PaternogaHR&C GmbH, Germany.
Jorid KalsethSINTEF Health Services Research, Klæbuveien 153, Trondheim 7037, Norway.
SINTEF · NOAalborg University · DKEuropean Social Observatory · BEFinnish Institute of Occupational Health · FILund University · SEMaastricht University · NLManchester Academic Health Science Centre · GBRuhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Covid-19 pandemic has revealed the importance of social protection systems, including income security, when health problems arise. The aims of this study are to compare the follow-up regimes for sick-listed employees across nine European countries, and to conduct a qualitative assessment of the differences with respect to burden and responsibility sharing between the social protection system, employers and employees. The tendency highlighted is that countries with shorter employer periods of sick-pay typically have stricter follow-up responsibility for employers because, in practice, they become gatekeepers of the public sickness benefit scheme. In Germany and the UK, employers have few requirements for follow-up compared with the Nordic countries because they bear most of the costs of sickness absence themselves. The same applies in Iceland, where employers carry most of the costs and have no obligation to follow up sick-listed employees. The situation in the Netherlands is paradoxical: employers have strict obligations in the follow-up regime even though they cover all the costs of the sick-leave themselves. During the pandemic, the majority of countries have adjusted their sick-pay system and increased coverage to reduce the risk of spreading Covid-19 because employees are going to work sick or when they should self-quarantine, except for the Netherlands and Belgium, which considered that the current schemes were already sufficient to reduce that risk.

Indexed as

COVID-19PandemicsEmploymentFollow-Up StudiesHumansSick Leavecomparative studyEuropean countriessickness absenteeismsickness benefitsick-pay

Identifiers

PMID35577620
PMCPMC9085445
OpenAlexW4229447182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.